Evolution of Mortality over Time in Patients Receiving Mechanical Ventilation

Esteban, Andrés; Frutos‐Vivar, Fernando; Muriel, Alfonso; Ferguson, Niall D.; Peñuelas, Óscar; Abraira, Víctor; Raymondos, Konstantinos; Ríos, Fernando; Nin, Nicolás; Apezteguía, Carlos; Violi, Damian A.; Thille, Arnaud W.; Brochard, Laurent; González, Marco; Villagómez, Asisclo; Hurtado, Javier; Davies, Andrew R.; Du, Bin; Maggiore, Salvatore Maurizio; Pelosi, Paolo; Soto, Luis; Tomicić, Vinko; D’Empaire, Gabriel; Matamis, Dimitrios; Abroug, Fékri; Moreno, Rui P.; Soares, Marco Antonio; Arabi, Yaseen M.; Sandi, Freddy; Jibaja, Manuel; Amin, Pravin; Koh, Younsuck; Kuiper, Michael; Bülow, Hans-Henrik; Zeggwagh, Amine Ali; Anzueto, Antonio

doi:10.1164/rccm.201212-2169oc

Cited by 555 publications

(476 citation statements)

References 42 publications

Supporting

Mentioning

397

Contrasting

Unclassified

Order By: Relevance

“…Mortality rates of patients with the acute respiratory distress syndrome (ARDS) are high [1,2]. Biological markers as well as disease severity scoring systems may be useful for risk stratification and the creation of homogenous patient groups in clinical trials [3].…”

Section: Introductionmentioning

confidence: 99%

Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients

et al. 2015

View full text Add to dashboard Cite

Purpose: We investigated the prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) on day 1 in patients with the acute respiratory distress syndrome (ARDS) for intensive care unit (ICU) mortality and compared it with established disease severity scores on day 1. Methods: suPAR was determined batchwise in plasma obtained within 24 h after admission. Results: 632 ARDS patients were included. Significantly (P = 0.02) higher median levels of suPAR were found with increasing severity of ARDS: 5.9 ng/ml [IQR 3.1-12.8] in mild ARDS (n = 82), 8.4 ng/ml .0] in moderate ARDS (n = 333), and 9.0 ng/ml .0] in severe ARDS (n = 217). Non-survivors had higher median levels of suPAR [12.5 ng/ml (IQR 5.1-19.5) vs. 7.4 ng/ml (3.9-13.6), P \ 0.001]. The area under the receiver operator characteristic curve (ROC-AUC) for mortality of suPAR (0.62) was lower than the ROC-AUC of the APACHE IV score (0.72, P = 0.007), higher than that of the ARDS definition classification (0.53, P = 0.005), and did not differ from that of the SOFA score (0.68, P = 0.07) and the oxygenation index (OI) (0.58, P = 0.29). Plasma suPAR did not improve the discrimination of the established disease severity scores, but did improve net reclassification of the APACHE score (29 %), SOFA score (23 %), OI (38 %), and Berlin definition classification (39 %). Conclusion: As a single biological marker, the prognostic value for death of plasma suPAR in ARDS patients is low. Plasma suPAR, however, improves the net reclassification, suggesting a potential role for suPAR in ICU mortality prediction models.

show abstract

Section: Introductionmentioning

confidence: 99%

Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Durch die mittlerweile weitverbreitete Anwendung der protektiven Beatmung mit einem Tidalvolumen von 6 ml/kgKG und der Begrenzung des Spitzendrucks auf 30 mbar sowie die Titration des positiven endexspiratorischen Drucks ("positive end-expiratory pressure", PEEP) konnten die durch mechanischen Stress der alveolokapillären Einheit induzierten pathologischen Veränderungen ("ventilator-associated lung injury", VALI, [3]) reduziert werden.…”

Section: Spontanatmung Im Entwöhnungsprozess Technische Spielerei Odeunclassified

Augmentierte Spontanatmung im Entwöhnungsprozess

Ragaller

2014

Anaesthesist

View full text Add to dashboard Cite

“…Based on the results of the largest epidemiological multinational study on mechanical ventilation, 14 % of the 18,302 included patients required a tracheostomy during their stay in the intensive care unit [1]. Two recent meta-analyses found no significant impact of early compared with late tracheostomy on duration of mechanical ventilation, length of ICU stay, or mortality rate [2,3].…”

mentioning

confidence: 99%